Home

The Problem

Neglected tropical diseases (NTDs) are a group of parasitic and bacterial infectious diseases that affect more than1.5 billion of the world’s most impoverished people, including 868 million children.

  • Intestinal Worms:

    1.5BRequire Treatment

  • Lymphatic Filariasis:

    892MRequire Treatment

  • River Blindness:

    205MRequire Treatment

  • Schistosomiasis:

    220MRequire Treatment

  • Trachoma:

    158MRequire Treatment

Our Vision

To ensure people at risk of neglected tropical diseases can live healthy and prosperous lives.

Our Impact

97M

97M People Treated in 2017

500M

500M Number of Treatments from 2012-2017

$933M

$933M Value of Treatments from 2012-2017

1.1M

1.1M Health Workers Trained from 2012-2017

11,584

11,584 Surgeries Performed from 2012-2017

The story of the END Fund

Play Video

Where We Work

News & Updates

Children in line for a mass drug administration in Rwanda for neglected tropical disease treatment

Our favorite neglected tropical disease stories from 2018

||

We can’t officially start the new year without reflecting on the past, so we are kicking off 2019 with some of our favorite stories from the last 12 months. From the launch of innovative new treatments to the rising global profile of neglected tropical diseases (NTDs), here is what made 2018 one of the best…

A look back at 2018

||

2018 was a fantastic year for the neglected tropical disease (NTD) community. With our partners, we treated more than 120 million people with over 230 million treatments valued at approximately $345 million. We helped train more than 600k health workers and provided over 1,700 surgeries for people with advanced stages of trachoma and lymphatic filariasis.

In pictures: Launch of IDA Drug Therapy Pilot Program in Kenya

||

In a historic moment, the Kenyan Ministry of Health piloted a new drug therapy for lymphatic filariasis in November 2018. IDA (ivermectin, diethylcarbamazine, albendazole) treatment has the potential to reduce the time to treat and break transmission of lymphatic filariasis (LF) from at least five years down to just two years. Globally, 892 million people…

Breakthrough Lymphatic Filariasis Treatment Piloted in Kenya – a First for Africa

||

NAIROBI, Kenya, Nov 15 — IDA treatment, a new triple drug therapy with the potential to reduce the time to treat and break transmission of lymphatic filariasis (LF) from at least five years down to two years, will be piloted today in a tremendous effort led by the Kenyan Ministry of Health and supported by…